• Wondering if HCA Healthcare at around US$428.79 is still offering value, or if most of the opportunity is already reflected in the price.
• The stock has seen a 9.1% decline over the last 30 days and is down 8.8% year to date, yet it has delivered a 21.0% return over 1 year and 116.3% over 5 years.
• Recent coverage has focused on how a large hospital operator like HCA Healthcare fits into investors' views on healthcare spending and hospital capacity. There has been attention on how its scale and network position it within the sector. Commentary has also highlighted how hospital operators may be reacting to cost pressures, capital spending plans, and changing patient volumes, which helps frame the recent share price moves.
• HCA Healthcare currently holds a valuation score of 5 out of 6. The sections that follow will compare different valuation methods to that score, then finish by looking at a more complete way to think about value that goes beyond a single model.

Approach 1: HCA Healthcare Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a stock could be worth by projecting future cash flows and discounting them back to today using a required rate of return.

For HCA Healthcare, the model uses a 2 Stage Free Cash Flow to Equity approach based on cash flow projections. The company’s last twelve months Free Cash Flow is about $7.8b. Analyst estimates and subsequent extrapolations by Simply Wall St point to projected Free Cash Flow of $8.1b in 2030, with detailed annual projections between 2026 and 2035 discounted back to today.

Bringing all those projected cash flows into today’s dollars gives an estimated intrinsic value of about $808.53 per share. Compared with a current share price of roughly $428.79, the DCF indicates the stock trades at about a 47.0% discount. This suggests the market price is materially below this cash flow based estimate.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests HCA Healthcare is undervalued by 47.0%. Track this in your watchlist or portfolio, or discover 51 more high quality undervalued stocks.

Approach 2: HCA Healthcare Price vs Earnings

For profitable companies like HCA Healthcare, the P/E ratio is a widely used way to relate what you are paying for the stock to the company’s current earnings. It helps you see how many dollars investors are paying today for each dollar of earnings.

What counts as a “normal” or “fair” P/E ratio usually reflects how the market views a company’s growth prospects and risk. Higher growth and lower perceived risk often support a higher P/E, while lower growth and higher risk tend to align with a lower P/E.

HCA Healthcare currently trades on a P/E of about 14.0x. That sits below the Healthcare industry average of about 25.2x and also below the peer group average of roughly 15.4x. Simply Wall St’s Fair Ratio for HCA Healthcare is 25.7x, which is its proprietary estimate of what the P/E could be given factors such as earnings growth, profit margins, industry, market capitalisation and company specific risks.

This Fair Ratio is more tailored than a simple comparison with peers or the broad industry, because it folds in company specific fundamentals rather than just sector averages. Comparing the Fair Ratio of 25.7x with the current P/E of 14.0x suggests the stock trades below that model based estimate.

Result: UNDERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your HCA Healthcare Narrative

Earlier it was mentioned that there is an even better way to understand valuation, so Narratives are introduced as a simple way for you to attach a clear story about HCA Healthcare to the numbers you use for fair value, future revenue, earnings and margins. This links that story to a forecast and then to a fair value that you can compare with the current share price to help decide whether to act. On Simply Wall St’s Community page, Narratives are an accessible tool used by millions of investors, updating automatically when new information such as news, guidance or earnings is added, so your story and valuation stay current without extra work from you. For HCA Healthcare, one investor might lean on a higher fair value like US$629.14 and a future P/E of 17.24x because they focus on scale, cash flow and capital allocation. Another might anchor closer to US$535.00 and a future P/E of 16.27x, reflecting more weight on risks around regulation, Medicaid and costs. Narratives allow both views to sit side by side so you can see how different assumptions lead to different conclusions.

Do you think there's more to the story for HCA Healthcare? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.